http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108863846-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
filingDate 2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108863846-B
titleOfInvention Preparation method of intermediate of lodoxylamine tromethamine
abstract The invention belongs to the technical field of pharmaceutical chemicals, and particularly discloses a preparation method of a lodoxylamine tromethamine intermediate, namely lodoxylamine, which comprises the following steps of (1) dissolving 3, 5-diamino-4-chlorobenzonitrile in an organic solvent to form a solution A; (2) dissolving oxalyl chloride in an organic solvent to form a solution B; (3) slowly dripping the solution A into the solution B, controlling the temperature of the reaction solution to be between 20 ℃ below zero and 0 ℃ in the dripping process, slowly dripping a certain amount of ice water into the reaction solution after the reaction is finished, continuously stirring for 0.5 to 1 hour after the dripping is finished, performing suction filtration, and drying the obtained filter cake to obtain the lodoxylamine. The method has the advantages of few reaction steps, more convenience for operation, greatly improved yield, high purity of the product, namely the lodoxylamine, of more than 90 percent, fewer related impurities, high purity of the product, high HPLC (high performance liquid chromatography) purity of more than 99.5 percent, and great significance for synthesis of the lodoxylamine tromethamine medicament.
priorityDate 2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425539605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414810016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426192434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9877341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451938659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12402995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21906498

Total number of triples: 33.